menu
    • menu

    Company profile for Innoviva Specialty Therapeutics

    NEW Drugs in Dev: 5
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Innoviva Specialty Therapeutics is dedicated to advancing innovative treatments for serious diseases, focusing on oncology and infectious diseases. With a commitment to improving patient outcomes, the company develops a diverse pipeline of novel therapies targeting unmet medical needs. Leveraging expertise in drug development and a patient-centric approach, Innoviva Specialty Therapeutics aims to deliver transformative solutio...
    Innoviva Specialty Therapeutics is dedicated to advancing innovative treatments for serious diseases, focusing on oncology and infectious diseases. With a commitment to improving patient outcomes, the company develops a diverse pipeline of novel therapies targeting unmet medical needs. Leveraging expertise in drug development and a patient-centric approach, Innoviva Specialty Therapeutics aims to deliver transformative solutions to healthcare challenges. By addressing critical gaps in treatment, the company strives to make a meaningful impact on patients’ lives worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Innoviva Specialty TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    930 Winter Street Suite 1500 Waltham, MA USA 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://innovivaspecialtytherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASCO GU

    ASCO GU

    Not Confirmed

    envelop Contact Supplier

    ASCO GU

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innoviva's Q4, Full-Year 2025 Results Highlight Company Progress
    Innoviva's Q4, Full-Year 2025 Results Highlight Company Progress

    25 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260225055287/en/Innoviva-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-Highlights-Recent-Company-Progress

    BUSINESSWIRE
    25 Feb 2026
    Share Share
    Innoviva Joins Oppenheimer Healthcare Life Sciences Conference
    Innoviva Joins Oppenheimer Healthcare Life Sciences Conference

    19 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260219756566/en/Innoviva-to-Participate-in-the-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference

    BUSINESSWIRE
    19 Feb 2026
    Share Share
    FDA Approves Nuzolvence for Uncomplicated Urogenital Gonorrhea
    FDA Approves Nuzolvence for Uncomplicated Urogenital Gonorrhea

    12 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251212683585/en/U.S.-FDA-Approves-NUZOLVENCE-zoliflodacin-a-First-in-Class-Single-dose-Oral-Antibiotic-for-the-Treatment-of-Uncomplicated-Urogenital-Gonorrhea-in-Adults-and-Adolescents

    BUSINESSWIRE
    12 Dec 2025
    Share Share
    Innoviva Joins 37Th Piper Sandler Healthcare Conference
    Innoviva Joins 37Th Piper Sandler Healthcare Conference

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125545821/en/Innoviva-to-Participate-in-the-37th-Annual-Piper-Sandler-Healthcare-Conference

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    Innoviva Specialty Therapeutics Presents Zoliflodacin Phase 3
    Innoviva Specialty Therapeutics Presents Zoliflodacin Phase 3

    20 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-20/innoviva-specialty-therapeutics-announces-oral-presentation-featuring-new-analyses-from-the-zoliflod

    PHARMIWEB
    20 Oct 2025
    Share Share
    Innoviva To Deliver Six ID & Critical Care Talks At IDWeek 2025
    Innoviva To Deliver Six ID & Critical Care Talks At IDWeek 2025

    07 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-07/innoviva-specialty-therapeutics-to-deliver-six-presentations-from-its-infectious-diseases-and-critic

    PHARMIWEB
    07 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search